Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud H Elbatreek

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cardiovascular Research|June 4, 2026
RUNX1: a new beat in the heart of diastolic dysfunctionMahmoud H Elbatreek, David J Lefer
Circulation Research|September 25, 2025
Unlocking Mitochondrial Potential: DWORF to the Rescue in Heart FailureMahmoud H Elbatreek, David J Lefer
Handbook of Experimental Pharmacology|August 12, 2020
NOX Inhibitors: From Bench to Naxibs to BedsideMahmoud H Elbatreek, Hermann Mucke, Harald H H W Schmidt
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 8, 2022
Current advances on the therapeutic potential of pinocembrin: An updated reviewMahmoud H Elbatreek, Ismail Mahdi, Wafae Ouchari, et al.
European Journal of Pharmacology|August 11, 2025
Agomelatine and Empagliflozin Synergistically Protect Against Diabetic Cardiomyopathy via Nrf2/HO-1 SignalingNada A Elbaik, Shimaa M Elshazly, Atef El-Gharbawy, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
<i>Agathis robusta</i> Bark Extract Protects from Renal Ischemia-Reperfusion Injury: Phytochemical, <i>In Silico</i> and <i>In Vivo</i> StudiesMaged E Mohamed, Nora Tawfeek, Samar S Elbaramawi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
Synergistic alleviation of obesity and associated cardiovascular complications by combined modulation of FASN/Arginase/eNOS uncouplingEbtesam Ahmed Sabry, Mahmoud H Elbatreek, Hany M El-Basossy, et al.
Toxicology and Applied Pharmacology|May 13, 2026
Paroxetine attenuates doxorubicin-induced cardiotoxicity: Integrated network pharmacology, molecular modeling, and in vivo evidence consistent with modulation of GRK2/iNOS-related pathwaysMahmoud Nabil, Rasha Abdel-Ghany, Nader E Abo-Dya, et al.
European Journal of Pharmacology|September 28, 2023
Repurposing alagebrium for diabetic foot ulcer healing: Impact on AGEs/NFκB/NOX1 signalingAfnan Harb, Mahmoud H Elbatreek, Ahmed Elshahat, et al.
Trends in Endocrinology and Metabolism: TEM|April 1, 2019
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ DamageMahmoud H Elbatreek, Mayra P Pachado, Antonio Cuadrado, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cardiovascular Research|June 4, 2026
RUNX1: a new beat in the heart of diastolic dysfunctionMahmoud H Elbatreek, David J Lefer
Circulation Research|September 25, 2025
Unlocking Mitochondrial Potential: DWORF to the Rescue in Heart FailureMahmoud H Elbatreek, David J Lefer
Handbook of Experimental Pharmacology|August 12, 2020
NOX Inhibitors: From Bench to Naxibs to BedsideMahmoud H Elbatreek, Hermann Mucke, Harald H H W Schmidt
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 8, 2022
Current advances on the therapeutic potential of pinocembrin: An updated reviewMahmoud H Elbatreek, Ismail Mahdi, Wafae Ouchari, et al.
European Journal of Pharmacology|August 11, 2025
Agomelatine and Empagliflozin Synergistically Protect Against Diabetic Cardiomyopathy via Nrf2/HO-1 SignalingNada A Elbaik, Shimaa M Elshazly, Atef El-Gharbawy, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2022
<i>Agathis robusta</i> Bark Extract Protects from Renal Ischemia-Reperfusion Injury: Phytochemical, <i>In Silico</i> and <i>In Vivo</i> StudiesMaged E Mohamed, Nora Tawfeek, Samar S Elbaramawi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
Synergistic alleviation of obesity and associated cardiovascular complications by combined modulation of FASN/Arginase/eNOS uncouplingEbtesam Ahmed Sabry, Mahmoud H Elbatreek, Hany M El-Basossy, et al.
Toxicology and Applied Pharmacology|May 13, 2026
Paroxetine attenuates doxorubicin-induced cardiotoxicity: Integrated network pharmacology, molecular modeling, and in vivo evidence consistent with modulation of GRK2/iNOS-related pathwaysMahmoud Nabil, Rasha Abdel-Ghany, Nader E Abo-Dya, et al.
European Journal of Pharmacology|September 28, 2023
Repurposing alagebrium for diabetic foot ulcer healing: Impact on AGEs/NFκB/NOX1 signalingAfnan Harb, Mahmoud H Elbatreek, Ahmed Elshahat, et al.
Trends in Endocrinology and Metabolism: TEM|April 1, 2019
Reactive Oxygen Comes of Age: Mechanism-Based Therapy of Diabetic End-Organ DamageMahmoud H Elbatreek, Mayra P Pachado, Antonio Cuadrado, et al.
Pageof 4